Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature

Angiogenesis

Volumn 12, Issue 1, 2009, Pages 91-100

  Fogal, Valentina ^a   Sugahara, Kazuki N ^b   Ruoslahti, Erkki ^a,b   Christian, Sven ^a,c  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BHC BSP GDD GTR TD Target Research   (Germany)

Author keywords

Angiogenesis; Bcl 2; Homing peptides; Tumor targeting

Indexed keywords

ANTIBODY; MESSENGER RNA; NCL 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NUCLEOLIN; NUCLEOLIN ANTIBODY; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TISSUE OXYGENATION; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES; APOPTOSIS; BASEMENT MEMBRANE; CELL HYPOXIA; CELL MEMBRANE; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; PERICYTES; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 61449216884     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-009-9137-5     Document Type: Article

References (32)

1. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 3 353 364 10.1016/S0092-8674(00) 80108-7
2. E Ruoslahti 2002 Specialization of tumour vasculature Nat Rev Cancer 2 2 83 90 10.1038/nrc724
3. B St Croix C Rago V Velculescu 2000 Genes expressed in human tumor endothelium Science 289 5482 1197 1202 10.1126/science.289.5482.1197
4. D Fukumura RK Jain 2007 Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization Microvasc Res 74 2-3 72 84 10.1016/j.mvr.2007.05.003
5. N Ferrara KJ Hillan HP Gerber 2004 Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat Rev Drug Discov 3 5 391 400 10.1038/nrd1381
6. S Christian J Pilch ME Akerman 2003 Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels J Cell Biol 163 4 871 878 10.1083/jcb.200304132
7. Y Huang H Shi H Zhou 2006 The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin Blood 107 9 3564 3571 10.1182/blood-2005-07-2961
8. D Destouches D El Khoury Y Hamma-Kourbali 2008 Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin PLoS ONE 3 6 e2518 10.1371/journal.pone.0002518
9. H Ginisty H Sicard B Roger 1999 Structure and functions of nucleolin J Cell Sci 112 Pt 6 761 772
10. M Srivastava HB Pollard 1999 Molecular dissection of nucleolin's role in growth and cell proliferation: new insights FASEB J 13 14 1911 1922
11. RA Borer CF Lehner HM Eppenberger 1989 Major nucleolar proteins shuttle between nucleus and cytoplasm Cell 56 3 379 390 10.1016/0092-8674(89)90241-9
12. D Yu MZ Schwartz R Petryshyn 1998 Effect of laminin on the nuclear localization of nucleolin in rat intestinal epithelial IEC-6 cells Biochem Biophys Res Commun 247 1 186 192 10.1006/bbrc.1998.8754
13. G Harms R Kraft G Grelle 2001 Identification of nucleolin as a new L-selectin ligand Biochem J 360 Pt 3 531 538 10.1042/0264-6021:3600531
14. EA Said B Krust S Nisole 2002 The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor J Biol Chem 277 40 37492 37502 10.1074/jbc.M201194200
15. JF Sinclair AD O'Brien 2002 Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7 J Biol Chem 277 4 2876 2885 10.1074/jbc.M110230200
16. M Fahling A Steege A Perlewitz 2005 Role of nucleolin in posttranscriptional control of MMP-9 expression Biochim Biophys Acta 1731 1 32 40
17. Y Otake S Soundararajan TK Sengupta 2007 Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA Blood 109 7 3069 3075
18. S Soundararajan W Chen EK Spicer 2008 The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells Cancer Res 68 7 2358 2365 10.1158/0008-5472.CAN-07-5723
19. H Shi Y Huang H Zhou 2007 Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin Blood 110 8 2899 2906 10.1182/blood-2007-01-064428
20. DL Fulgham SR Widhalm S Martin 1999 FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice Endothelium 6 3 185 195 10.3109/10623329909053409
21. CV Ngo M Gee N Akhtar 2000 An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype Cell Growth Differ 11 4 201 210
22. J Zhang G Tsaprailis GT Bowden 2008 Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation Cancer Res 68 4 1046 1054 10.1158/0008-5472.CAN-07-1927
23. S Morikawa P Baluk T Kaidoh 2002 Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors Am J Pathol 160 3 985 1000
24. M Dhanabal R Ramchandran MJ Waterman 1999 Endostatin induces endothelial cell apoptosis J Biol Chem 274 17 11721 11726 10.1074/jbc.274.17.11721
25. A Abdollahi P Hahnfeldt C Maercker 2004 Endostatin's antiangiogenic signaling network Mol Cell 13 5 649 663 10.1016/S1097-2765(04)00102-9
26. RK Jain 2005 Antiangiogenic therapy for cancer: current and emerging concepts Oncology 19 4, Suppl 3 7 16 Williston Park
27. PV Dickson JB Hamner TL Sims 2007 Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy Clin Cancer Res 13 13 3942 3950 10.1158/1078-0432.CCR-07-0278
28. J Hamzah M Jugold F Kiessling 2008 Vascular normalization in Rgs5-deficient tumours promotes immune destruction Nature 453 7193 410 414 10.1038/nature06868
29. F Winkler SV Kozin RT Tong 2004 Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases Cancer Cell 6 6 553 563
30. RK Jain 2008 Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer Nat Rev Cancer 8 4 309 316 10.1038/nrc2346
31. RS Herbst VJ O'Neill L Fehrenbacher 2007 Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer J Clin Oncol 25 30 4743 4750 10.1200/JCO.2007.12.3026
32. A Sandler R Gray MC Perry 2006 Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer N Engl J Med 355 24 2542 2550 10.1056/NEJMoa061884